| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 1111-1118, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
ST Traweek, J Liu and H Battifora
Sylvia Cowan Laboratory of Surgical Pathology, City of Hope National Medical Center, Duarte, California 91010.
Keratin filament are characteristically present in epithelial cells and tumors, but have also been detected in many normal and neoplastic non- epithelial cell types using immunohistochemical techniques. To investigate the validity of this seemingly aberrant protein expression, we applied the highly sensitive polymerase chain reaction (PCR) technique to study keratin gene expression in a variety of non- epithelial tissues. Total RNA was extracted from nine samples of leiomyosarcoma, four non-Hodgkin's lymphoma, seven normal bone marrows, normal lymph node, normal peripheral blood cells, freshly isolated and cultured endothelial cells, cultured skin fibroblasts, and the myeloid leukemia cell line HL-60. Amplification primers and probes for the three most primitive keratin types (8, 18, and 19) were synthesized using published gene sequences. RNA from the breast carcinoma cell line MCF-7, known to be rich in all three keratins, was used as positive control. Concurrently run actin primers were used to confirm RNA integrity. After an initial cycle with reverse transcriptase, PCR amplification was performed for 30 cycles. Southern blots of the PCR products showed variably intense bands corresponding to keratin 8 and 18 gene products in all samples, offering conclusive evidence of keratin gene expression in cells of both stromal and hematopoietic derivation. However, keratin 19 gene transcription was not nearly so ubiquitous, being detected in normal fibroblasts and endothelial cells, two of four non-Hodgkin's lymphoma and four of nine leiomyosarcoma, but not in normal lymph node, peripheral blood cells, HL-60 cells, or any of the seven normal bone marrows examined. Dilutional experiments showed PCR to be highly sensitive in the detection of keratin 19 gene expression, capable of registering one MCF-7 cell in 10(6) HL-60 cells. These studies show that variable levels of keratin 8 and 18 gene expression may be detected by PCR in a wide variety of non-epithelial tissues, supporting previous immunohistochemical and phylogenetic studies. However, keratin 19 gene expression appears to be more restricted and was not evident in any hematopoietic cells devoid of contaminating stromal elements. These findings suggest a role for PCR in the detection of epithelial micrometastasis in certain sites, particularly bone marrow.
This article has been cited by other articles:
![]() |
S. Roy, D. Patel, S. Khanna, G. M. Gordillo, S. Biswas, A. Friedman, and C. K. Sen Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue PNAS, September 4, 2007; 104(36): 14472 - 14477. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Herzog, J. Van Arnam, B. Hu, and D. S. Krause Threshold of lung injury required for the appearance of marrow-derived lung epithelia. Stem Cells, August 1, 2006; 24(8): 1986 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Janni, B. Rack, K. Lindemann, and N. Harbeck Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time? Oncologist, August 1, 2005; 10(7): 480 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Reinholz, A. Nibbe, L. M. Jonart, K. Kitzmann, V. J. Suman, J. N. Ingle, R. Houghton, B. Zehentner, P. C. Roche, and W. L. Lingle Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3722 - 3732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasumoto, T. Osaki, Y. Watanabe, H. Kato, and T. Yoshimura Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study Ann. Thorac. Surg., July 1, 2003; 76(1): 194 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakaguchi, A. Virmani, M. W. Dudak, G. N. Peters, A. M. Leitch, H. Saboorian, A. F. Gazdar, and D. M. Euhus Clinical Relevance of Reverse Transcriptase-Polymerase Chain Reaction for the Detection of Axillary Lymph Node Metastases in Breast Cancer Ann. Surg. Oncol., March 1, 2003; 10(2): 117 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stathopoulou, I. Vlachonikolis, D. Mavroudis, M. Perraki, Ch. Kouroussis, S. Apostolaki, N. Malamos, S. Kakolyris, A. Kotsakis, N. Xenidis, et al. Molecular Detection of Cytokeratin-19-Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance J. Clin. Oncol., August 15, 2002; 20(16): 3404 - 3412. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Osaki, T. Oyama, C.-D. Gu, T. Yamashita, T. So, M. Takenoyama, K. Sugio, and K. Yasumoto Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non-Small-Cell Lung Cancer J. Clin. Oncol., July 1, 2002; 20(13): 2930 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kawano, E. Hata, S. Ikeda, and H. Sakaguchi Micrometastasis to lymph nodes in stage I left lung cancer patients Ann. Thorac. Surg., May 1, 2002; 73(5): 1558 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fava, R. Desnoyers, S. Schulz, J. Park, D. Weinberg, E. Mitchell, and S. A. Waldman Ectopic Expression of Guanylyl Cyclase C in CD34+ Progenitor Cells in Peripheral Blood J. Clin. Oncol., October 1, 2001; 19(19): 3951 - 3959. [Abstract] [Full Text] |
||||
![]() |
C. D. Collard, M. C. Montalto, W. R. Reenstra, J. A. Buras, and G. L. Stahl Endothelial Oxidative Stress Activates the Lectin Complement Pathway : Role of Cytokeratin 1 Am. J. Pathol., September 1, 2001; 159(3): 1045 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. FLEMING and M. A. WATSON Mammaglobin, a Breast-Specific Gene, and Its Utility as a Marker for Breast Cancer Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 78 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, Y. Kobayashi, Y. Ishikawa, S. Tsuchiya, S. Okumura, K. Nakagawa, Y. Tokuchi, M. Hayashi, K. Nishida, S.-i. Hayashi, et al. Prognostic Value of Genetically Diagnosed Lymph Node Micrometastasis in Non-Small Cell Lung Carcinoma Cases Cancer Res., November 1, 2000; 60(22): 6472 - 6478. [Abstract] [Full Text] |
||||
![]() |
K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Watson, S. Dintzis, C. M. Darrow, L. E. Voss, J. DiPersio, R. Jensen, and T. P. Fleming Mammaglobin Expression in Primary, Metastatic, and Occult Breast Cancer Cancer Res., July 1, 1999; 59(13): 3028 - 3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Slade, B. M. Smith, H. D. Sinnett, N. C.P. Cross, and R. C. Coombes Quantitative Polymerase Chain Reaction for the Detection of Micrometastases in Patients With Breast Cancer J. Clin. Oncol., March 1, 1999; 17(3): 870 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tschentscher, C. Wagener, and M. Neumaier Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA Clin. Chem., December 1, 1997; 43(12): 2244 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maruyama, K. Sugio, T. Mitsudomi, G. Saitoh, T. Ishida, and K. Sugimachi RELATIONSHIP BETWEEN EARLY RECURRENCE AND MICROMETASTASES IN THE LYMPH NODES OF PATIENTS WITH STAGE I NON-SMALL-CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 535 - 543. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |